1:50 PM
 | 
Sep 13, 2017
 |  BC Extra  |  Company News

ProQR spins out rare disease play Amylon

ProQR Therapeutics N.V. (NASDAQ:PRQR) spun out CNS-focused Amylon Therapeutics B.V. (Leiden, the Netherlands), which simultaneously raised an undisclosed amount in a seed funding from private and institutional investors....

Read the full 128 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >